Latest & greatest articles for tuberculosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tuberculosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tuberculosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tuberculosis

143. Roadmap for zoonotic tuberculosis

Roadmap for zoonotic tuberculosis Roadmap for zoonotic tuberculosis JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Roadmap for zoonotic tuberculosis View/ Open View Statistics Altmetrics Share Citation World Health Organization , Food and Agriculture Organization of the United Nations & World Organisation for Animal Health . (‎2017)‎. Roadmap for zoonotic tuberculosis. World

2017 WHO

144. Hoja de ruta contra la tuberculosis zoonótica

Hoja de ruta contra la tuberculosis zoonótica Hoja de ruta contra la tuberculosis zoonótica JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Hoja de ruta contra la tuberculosis zoonótica View/ Open View Statistics Altmetrics Share Citation Organización Mundial de la Salud , Organización de las Naciones Unidas para la Alimentación y la Agricultura & Organización Mundial de (...) Sanidad Animal . (‎2017)‎. Hoja de ruta contra la tuberculosis zoonótica. Organización Mundial de la Salud. Description 20 p. ISBN 9789243513041 Other Language Versions Collections Language español Metadata Related items Showing items related by title and MeSH subject.  World Health Organization (‎ WHO/HTM/TB/2013.14 , 2013 )‎  World Health Organization (‎ 2014 )‎  Organisation mondiale de la Santé (‎ WHO/HTM/TB/2011.4 , 2011 )‎ View Item

2017 WHO

145. Roadmap for Zoonotic Tuberculosis

Roadmap for Zoonotic Tuberculosis FOR ZOONOTIC ROADMAP TUBERCULOSISRoadmap for zoonotic tuberculosis © World Health Organization (WHO), Food and Agriculture Organization of the United Nations (FAO) and World Organisation for Animal Health (OIE), 2017 ISBN 978-92-4-151304-3 (WHO) ISBN 978-92-5-109927-8 (FAO) ISBN 978-92-95108-51-6 (OIE) Publications of the World Health Organization are available on the WHO web site www.who.int or can be purchased from WHO Press, World Health Organization, 20 (...) Togami (The Union), Rea Tschopp (Swiss Tropical and Public Health Institute, Switzerland and Armauer Hansen Research Institute, Ethiopia), Paul van Helden (Stellenbosch University, South Africa), Angela Varnum (Colorado State University, USA), Jakob Zinsstag (Swiss Tropical and Public Health Institute, Switzerland) Production of this document was supported by a financial contribution from The International Union Against Tuberculosis and Lung Disease through U.S. Centers for Disease Control

2017 International Union Against TB and Lung Disease

146. Diagnosis of Tuberculosis in Adults and Children: Official ATS/IDSA/CDC Clinical Practice Guidelines

Diagnosis of Tuberculosis in Adults and Children: Official ATS/IDSA/CDC Clinical Practice Guidelines Clinical Infectious Diseases Diagnosis of TB in Adults and Children • CID 2017:64 (15 January) • e1 Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children David M. Lewinsohn, 1,a Michael K. Leonard, 2,a Philip A. LoBue, 3,a David L. Cohn, 4 Charles L. Daley (...) Health, Nashville, Tennessee, 14 Wisconsin State Laboratory of Hygiene, Madison, and 15 University of Arkansas for Medical Sciences, Little Rock Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuber- culosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its

2017 American Thoracic Society

147. Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (2016), 28 - 29 June 2016, Geneva, Switzerland

Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (2016), 28 - 29 June 2016, Geneva, Switzerland Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (‎2016)‎, 28 - 29 June 2016, Geneva, Switzerland JavaScript is disabled for your browser. Some features of this site may not work (...) without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (‎2016)‎, 28 - 29 June 2016, Geneva, Switzerland View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug

2017 WHO

148. Interventions to improve contact tracing for tuberculosis in specific groups and in wider populations: an evidence synthesis Full Text available with Trip Pro

Interventions to improve contact tracing for tuberculosis in specific groups and in wider populations: an evidence synthesis Interventions to improve contact tracing for tuberculosis in specific groups and in wider populations: an evidence synthesis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search

2017 NIHR HTA programme

149. Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis Full Text available with Trip Pro

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis A 75-year-old woman presented with a 10-day history of intermittent fever, general fatigue, and progressive dyspnea. Although she had a low PaO2/FIO2 ratio, the cause of acute respiratory distress syndrome was not clear until day 9 in hospital.We treated the patient with direct hemoperfusion with a polymyxin B-immobilized fiber column incidentally; the PaO2/FIO2 ratio improved following (...) this therapy. Acid-fast bacilli, which were not seen in the sputum on admission, were detected in cultures from sputum, urine, bone marrow, liver biopsy, and blood samples, with a real-time polymerase chain reaction assay confirming tuberculosis. She was immediately transferred to a specialized tuberculosis hospital, and after a 3-month treatment, was discharged.Treatment with polymyxin B-immobilized fiber column may provide good results for pulmonary oxygenation in acute respiratory distress syndrome

2016 Acute medicine & surgery

150. Providers' knowledge of diagnosis and treatment of tuberculosis using vignettes: evidence from rural Bihar, India Full Text available with Trip Pro

Providers' knowledge of diagnosis and treatment of tuberculosis using vignettes: evidence from rural Bihar, India Almost 25% of all new cases of tuberculosis (TB) worldwide are in India, where drug resistance and low quality of care remain key challenges.We conducted an observational, cross-sectional study of healthcare providers' knowledge of diagnosis and treatment of TB in rural Bihar, India, from June to September 2012. Using data from vignette-based interviews with 395 most commonly

2016 BMJ global health

151. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. Full Text available with Trip Pro

Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. Some of the most promising vaccines in the pipeline for tuberculosis (TB) target adolescents and adults. Unlike for childhood vaccines, high-coverage population-wide vaccination is significantly more challenging for adult vaccines. Here, we aimed to estimate the impact of vaccine delivery strategies that were targeted to high-incidence geographical 'hotspots' compared with randomly allocated vaccination. We

2016 Journal of the Royal Society, Interface Controlled trial quality: uncertain

152. Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings Full Text available with Trip Pro

Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings Preoperative diagnosis of peritoneal tuberculosis is often difficult because of confusion with ovarian cancer. A 56-year-old woman was admitted to our hospital with abdominal fullness. Ascites, prominent bilateral ovaries, and elevated CA-125 were noted. Computed tomography showed thickened peritoneum and strandings in the mesentery and omentum. Exploratory laparotomy (...) was performed under the provisional diagnosis of ovarian cancer, but the final diagnosis was peritoneal tuberculosis. Careful evaluation of bilateral fallopian tubes and ovaries and peritoneum are helpful for correct diagnosis.

2016 EXCLI journal

153. Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot Full Text available with Trip Pro

Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot Tuberculosis (TB) still remains the thorn in the flesh of efficient therapeutics affecting one-third of global population annually. There are several factors that enhance the susceptibility to TB infections including malnutrition, smoking, and immunocompromised conditions such as AIDS. In the recent years, growing body of evidence has gained considerable prominence which suggests that Diabetes Mellitus (DM) is individual risk

2016 International journal of chronic diseases

154. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland. Full Text available with Trip Pro

Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland. Tuberculosis elimination in countries with a low incidence of the disease necessitates multiple interventions, including innovations in migrant screening. We examined a cohort of migrants screened for tuberculosis before entry to England, Wales, and Northern Ireland and tracked the development (...) of disease in this group after arrival.As part of a pilot pre-entry screening programme for tuberculosis in 15 countries with a high incidence of the disease, the International Organization for Migration screened all applicants for UK visas aged 11 years or older who intended to stay for more than 6 months. Applicants underwent a chest radiograph, and any with results suggestive of tuberculosis underwent sputum testing and culture testing (when available). We tracked the development of tuberculosis

2016 Lancet

155. Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in Nigeria Full Text available with Trip Pro

Psychosocial wellbeing of patients with multidrug resistant tuberculosis voluntarily confined to long-term hospitalisation in Nigeria Patient isolation, which is a widely successful treatment strategy for tuberculosis (TB), has been suspected to have effects on patient psychosocial wellbeing. We assessed the psychosocial wellbeing of multidrug resistant TB (MDR-TB) patients in voluntary and isolated long-term hospitalisation in Nigeria.98 accessible and consenting patients in four drug

2016 BMJ global health

156. Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study. (Abstract)

Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.

2016 Lancet

157. Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study. Full Text available with Trip Pro

Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.

2016 Lancet

158. Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults Full Text available with Trip Pro

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults Systematic screening is often proposed as a way to improve case finding for tuberculosis (TB), but the cost-effectiveness of specific strategies for systematic screening remains poorly studied.We constructed a Markov-based decision analytic model to analyse the cost-effectiveness of triage testing for TB in Uganda, compared against passive case detection with Xpert MTB/RIF. We

2016 BMJ global health

159. Hematological and liver toxicity of anti-tuberculosis drugs Full Text available with Trip Pro

Hematological and liver toxicity of anti-tuberculosis drugs Tuberculosis (TB) is a major global health problem, and anti-tuberculosis drugs can cause severe adverse reactions. The aim of this study was to determine hematological and biochemical changes and associated risk factors in smear positive pulmonary tuberculosis patients undergoing treatment with standard protocols.In a descriptive study, a total of 40 tuberculosis patients aged between 15-60 years were collected from hospitals (...) , HCT, MCV, MCH, and MCHC), except platelet count, were changed significantly (p ≤ 0.001). Liver enzyme activities (ALT, AST, and ALP) were decreased significantly (p ≤ 0.001) after treatment.In this study, changes of hematological and biochemical parameters have been observed in patients with pulmonary tuberculosis. It can be concluded that the anti-tuberculosis treatment is associated with changes of hematological parameters and liver enzymes.

2016 Electronic physician

160. GenoType<sup>®</sup> MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. Full Text available with Trip Pro

GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. Genotype® MTBDRsl (MTBDRsl) is a rapid DNA-based test for detecting specific mutations associated with resistance to fluoroquinolones and second-line injectable drugs (SLIDs) in Mycobacterium tuberculosis complex. MTBDRsl version 2.0 (released in 2015) identifies the mutations detected by version 1.0, as well as additional mutations. The test may be performed on a culture isolate or a patient specimen (...) , which eliminates delays associated with culture. Version 1.0 requires a smear-positive specimen, while version 2.0 may use a smear-positive or -negative specimen. We performed this updated review as part of a World Health Organization process to develop updated guidelines for using MTBDRsl.To assess and compare the diagnostic accuracy of MTBDRsl for: 1. fluoroquinolone resistance, 2. SLID resistance, and 3. extensively drug-resistant tuberculosis, indirectly on a M. tuberculosis isolate grown from

2016 Cochrane